Withdrawal of insulin therapy after adjunctive treatment with acarbose in a patient with Type 2 diabetes mellitus

摘要

AbstractAcarbose has been shown to reduce post‐prandial hyperglycaemia and improve glycaemic control in patients with Type 2 diabetes mellitus. We report its use as an adjunct to established insulin therapy in a 64 year old man with Type 2 diabetes mellitus and secondary failure to treatment with a sulphonylurea. Following the addition of acarbose to his treatment regimen his insulin therapy was completely withdrawn. Associated with this was a documented weight loss of 7kg and reduction in glycated haemoglobin of 2.7. Acarbose can be of potential benefit in the management of poorly controlled Type 2 diabete